• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑膜瘤脑侵犯的预后意义:系统评价和荟萃分析。

Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

机构信息

Division of Neurosurgery, Kusatsu General Hospital, Yabase-cho 1660, Kusatsu, Shiga, 525-8585, Japan.

Department of Neurosurgery, Shiga University of Medical Science, Ohtsu, Japan.

出版信息

Brain Tumor Pathol. 2021 Apr;38(2):81-95. doi: 10.1007/s10014-020-00390-y. Epub 2021 Jan 6.

DOI:10.1007/s10014-020-00390-y
PMID:33403457
Abstract

The WHO 2016 classification introduced brain invasion as a standalone criterion for grade II meningioma (GIIM). We systematically reviewed studies published after 2000 and performed a PRISMA-compliant meta-analysis of the hazard ratios (HRs) for progression-free survival (PFS) between brain-invasive and noninvasive meningiomas. In five studies that included both benign and higher-grade meningiomas, brain invasion was a significant risk factor for recurrence (HR = 2.45, p = 0.0004). However, in 3 studies comparing "brain-invasive meningioma with otherwise benign histology (BIOB)" with grade I meningioma, brain invasion was not a significant predictor of PFS (HR = 1.49, p = 0.23). Among GIIM per the WHO 2000 criteria, brain invasion was a significant predictor of shorter PFS than noninvasive GIIM (HR = 3.40, p = 0.001) but not per the WHO 2016 criteria (HR 1.13, p = 0.54), as the latter includes BIOB. Meta-regression analysis of seven studies of grade II meningioma showed that more frequent BIOB was associated with lower HRs (p < 0.0001). Hence, there is no rationale for brain invasion as a standalone criterion for grade II meningioma, although almost all studies were retrospective and exhibited highly heterogeneous HRs due to differences in brain-tumor interface data availability.

摘要

世界卫生组织 2016 年分类将脑侵犯作为 II 级脑膜瘤(GIIM)的独立标准。我们系统地回顾了 2000 年后发表的研究,并对无进展生存期(PFS)的风险比(HR)进行了符合 PRISMA 标准的荟萃分析,比较了脑侵犯和非侵犯性脑膜瘤之间的差异。在包括良性和高级别脑膜瘤的 5 项研究中,脑侵犯是复发的显著危险因素(HR=2.45,p=0.0004)。然而,在 3 项比较“具有脑侵犯特征但组织学良性的脑膜瘤(BIOB)”与 I 级脑膜瘤的研究中,脑侵犯并不是 PFS 的显著预测因子(HR=1.49,p=0.23)。在 2000 年 WHO 分级的 GIIM 中,脑侵犯是 PFS 较短的显著预测因子,而非 2016 年 WHO 分级的 GIIM(HR=3.40,p=0.001),因为后者包括了 BIOB。对 7 项 II 级脑膜瘤研究的荟萃回归分析显示,更频繁的 BIOB 与更低的 HR 相关(p<0.0001)。因此,脑侵犯作为 II 级脑膜瘤的独立标准没有任何依据,尽管几乎所有研究都是回顾性的,并且由于脑肿瘤界面数据可用性的差异,HR 存在高度异质性。

相似文献

1
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.脑膜瘤脑侵犯的预后意义:系统评价和荟萃分析。
Brain Tumor Pathol. 2021 Apr;38(2):81-95. doi: 10.1007/s10014-020-00390-y. Epub 2021 Jan 6.
2
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.此前被归类为 WHO 分级 I 的脑膜瘤中的微观脑侵犯与患者预后无关。
J Neurooncol. 2019 Dec;145(3):469-477. doi: 10.1007/s11060-019-03312-x. Epub 2019 Nov 11.
3
Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.脑膜瘤的脑侵犯:发生率及其与临床变量和预后的相关性
World Neurosurg. 2016 Sep;93:346-54. doi: 10.1016/j.wneu.2016.06.055. Epub 2016 Jun 22.
4
The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas.脑膜瘤临床病理特征的预后意义:微观脑侵袭可预测其他方面为良性的脑膜瘤患者的预后。
Neuropathol Appl Neurobiol. 2021 Oct;47(6):724-735. doi: 10.1111/nan.12700. Epub 2021 Feb 25.
5
Meningioma grading: an analysis of histologic parameters.脑膜瘤分级:组织学参数分析
Am J Surg Pathol. 1997 Dec;21(12):1455-65. doi: 10.1097/00000478-199712000-00008.
6
Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.层粘连蛋白γ1 的表达与脑膜瘤分级、复发和无进展生存率的关系。
Acta Neurochir (Wien). 2013 Jan;155(1):165-71. doi: 10.1007/s00701-012-1512-0. Epub 2012 Oct 5.
7
"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.脑膜瘤中的“恶性”:116例患者的临床病理研究及其分级意义
Cancer. 1999 May 1;85(9):2046-56. doi: 10.1002/(sici)1097-0142(19990501)85:9<2046::aid-cncr23>3.0.co;2-m.
8
Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.非典型脑膜瘤的坏死和脑侵犯预测放射抵抗和肿瘤复发:一项回顾性队列研究。
Neurosurgery. 2020 Dec 15;88(1):E42-E48. doi: 10.1093/neuros/nyaa348.
9
Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?坏死是脑膜瘤复发的一个一致因素:它是否应该成为 II 级脑膜瘤的独立分级标准?
J Neurooncol. 2018 Apr;137(2):331-336. doi: 10.1007/s11060-017-2721-4. Epub 2017 Dec 21.
10
Clear cell histology portends a worse prognosis than other WHO grade II histologies.透明细胞组织学比其他世卫组织二级组织学预示着更差的预后。
J Neurooncol. 2021 Jan;151(2):307-312. doi: 10.1007/s11060-020-03668-5. Epub 2021 Jan 4.

引用本文的文献

1
Meningioma recurrence: Time for an online prediction tool?脑膜瘤复发:是时候推出在线预测工具了吗?
Surg Neurol Int. 2024 May 10;15:155. doi: 10.25259/SNI_43_2024. eCollection 2024.
2
Multiparameter MRI-based radiomics nomogram for preoperative prediction of brain invasion in atypical meningioma:a multicentre study.基于多参数 MRI 的放射组学列线图预测非典型脑膜瘤脑侵犯的术前预测:一项多中心研究。
BMC Med Imaging. 2024 Jun 5;24(1):134. doi: 10.1186/s12880-024-01294-5.
3
Radiotherapy and radiosurgery for meningiomas.脑膜瘤的放射治疗和放射外科治疗。

本文引用的文献

1
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.基于5个临床病理变量的风险评分可预测非典型脑膜瘤的复发
J Neuropathol Exp Neurol. 2020 May 1;79(5):500-507. doi: 10.1093/jnen/nlaa018.
2
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.此前被归类为 WHO 分级 I 的脑膜瘤中的微观脑侵犯与患者预后无关。
J Neurooncol. 2019 Dec;145(3):469-477. doi: 10.1007/s11060-019-03312-x. Epub 2019 Nov 11.
3
Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre.
Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i67-i83. doi: 10.1093/noajnl/vdac088. eCollection 2023 May.
4
Meningiomas with CNS invasion.伴有中枢神经系统侵犯的脑膜瘤。
Front Neurosci. 2023 Jun 29;17:1189606. doi: 10.3389/fnins.2023.1189606. eCollection 2023.
5
Base MRI Imaging Characteristics of Meningioma Patients to Discuss the WHO Classification of Brain Invasion Otherwise Benign Meningiomas.脑膜瘤患者的基础 MRI 成像特征,探讨其他良性脑膜瘤的 WHO 脑侵袭分类。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231171470. doi: 10.1177/15330338231171470.
6
Brain Invasion and Trends in Molecular Research on Meningioma.脑膜瘤的脑侵袭及分子研究趋势
Brain Tumor Res Treat. 2023 Jan;11(1):47-58. doi: 10.14791/btrt.2022.0044.
7
The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion.术前MRI特征在脑膜瘤WHO分级及脑侵袭诊断中的效能
Front Oncol. 2023 Jan 18;12:1100350. doi: 10.3389/fonc.2022.1100350. eCollection 2022.
8
Preoperative surgical risk assessment of meningiomas: a narrative review based on MRI radiomics.脑膜瘤的术前手术风险评估:基于 MRI 放射组学的叙述性综述。
Neurosurg Rev. 2022 Dec 28;46(1):29. doi: 10.1007/s10143-022-01937-7.
9
Updated Systematic Review on the Role of Brain Invasion in Intracranial Meningiomas: What, When, Why?关于脑侵犯在颅内脑膜瘤中作用的最新系统评价:是什么、何时发生、为何如此?
Cancers (Basel). 2022 Aug 27;14(17):4163. doi: 10.3390/cancers14174163.
10
M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF- Signaling Pathway.M2 巨噬细胞衍生的外泌体通过 TGF-β 信号通路促进脑膜瘤的进展。
J Immunol Res. 2022 May 20;2022:8326591. doi: 10.1155/2022/8326591. eCollection 2022.
与非典型颅内脑膜瘤术后复发相关的风险因素:单一神经外科中心 263 例分析。
Acta Neurochir (Wien). 2019 Dec;161(12):2563-2570. doi: 10.1007/s00701-019-04073-2. Epub 2019 Oct 22.
4
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.非典型性脑膜瘤的组织病理学特征及治疗失败风险:一项多机构分析。
World Neurosurg. 2020 Jan;133:e804-e812. doi: 10.1016/j.wneu.2019.10.002. Epub 2019 Oct 9.
5
Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology?脑膜瘤的脑侵犯:手术取样是否影响标本特征和组织学?
Neurosurg Rev. 2020 Apr;43(2):793-800. doi: 10.1007/s10143-019-01125-0. Epub 2019 Jun 3.
6
Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.高级别脑膜瘤的预后特征:预测进展和结局的组织病理学评分。
J Neuropathol Exp Neurol. 2019 Mar 1;78(3):248-256. doi: 10.1093/jnen/nly127.
7
High p-mTOR expression is associated with recurrence and shorter disease-free survival in atypical meningiomas.高磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)表达与非典型脑膜瘤的复发及较短的无病生存期相关。
Neuropathology. 2019 Feb;39(1):22-29. doi: 10.1111/neup.12524. Epub 2018 Dec 3.
8
Treatment Protocol, Long-Term Follow-Up, and Predictors of Mortality in 302 Cases of Atypical Meningioma.302例非典型脑膜瘤的治疗方案、长期随访及死亡率预测因素
World Neurosurg. 2019 Feb;122:e1275-e1284. doi: 10.1016/j.wneu.2018.11.032. Epub 2018 Nov 14.
9
Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection.非典型脑膜瘤全切除术后局部复发的病理预测因素。
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):453-459. doi: 10.1016/j.ijrobp.2018.09.019. Epub 2018 Sep 22.
10
TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.TERT 启动子突变与 WHO 分级 II 级和 III 级脑膜瘤的预后不良相关。
J Neurooncol. 2018 Sep;139(3):671-678. doi: 10.1007/s11060-018-2912-7. Epub 2018 May 28.